Myxone S 1000mg/500mg Injection
Marketer
Grefith Life Sciences Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Myxone S 1000mg/500mg Injection
Combiflox 1000mg/500mg Injection, a dual-action antibiotic, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, curbing infection spread. Administration must be under a doctor's guidance; strict adherence to the prescribed schedule is crucial. Complete the entire treatment course, regardless of symptom improvement; premature cessation may reduce efficacy. Potential side effects include nausea, vomiting, diarrhea, and digestive upset. Report worsening side effects immediately to your physician. Seek immediate medical attention for allergic reactions (rash, itching, swelling, respiratory distress). Inform your doctor of all current medications, including those for pre-existing conditions. Pregnant or lactating individuals must consult their doctor before use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and sufficient hydration will aid recovery. Your doctor might order tests to monitor the medication's effects.
Uses of Myxone S 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Myxone S 1000mg/500mg Injection:
Administering this medication will be done by your physician or their nursing staff; self-medication is strongly discouraged.
Common Side effects of Myxone S 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Myxone S 1000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Myxone S 1000mg/500mg Injection works:
Myxone S, a 1000mg/500mg injectable formulation, unites the antibiotic Ceftriaxone with the beta-lactamase inhibitor Sulbactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Sulbactam counteracts bacterial resistance mechanisms, thereby optimizing Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
Myxone S 1000mg/500mg Injection may be used concurrently with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Myxone S (1000mg/500mg) is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or absent harm to offspring; nonetheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Myxone S 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Myxone S 1000mg/500mg Injection can induce drowsiness, visual disturbances, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Myxone S 1000mg/500mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
The Myxone S 1000mg/500mg Injection requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Altering the Myxone S 1000mg/500mg Injection dosage is generally unnecessary for patients experiencing mild or moderate liver dysfunction.
What if you forget to take Myxone S 1000mg/500mg Injection :
Omitting a scheduled dose of Myxone S 1000mg/500mg Injection requires immediate physician consultation.
Facts to Know About Myxone S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently